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We describe here the case of a boy who presented with pulmonary infections, feeding dif-
ficulties due to velopharyngeal insufficiency and gastroesophageal reflux, myopathy, and 
hypotonia soon after birth. Later, he was also found to have an elevated immunoglobulin 
(Ig) E and mild eczema and was diagnosed with inflammatory bowel disease. Further 
immunological screening at the age of 7 years showed low B and NK cell numbers but 
normal CD4+ and CD8+ T cells and notably, normal numbers of CD4+ regulatory T (Treg) 
cells. Serum IgG, IgA, and IgM were low to normal, but he had a deficient response 
to a pneumococcal polysaccharide vaccine and thus a humoral immunodeficiency. To 
our surprise, whole exome sequencing revealed a mutation in forkhead box protein 3 
(FOXP3), encoding an essential transcription factor for the development and function of 
Treg cells. This classical mutation is associated with immune dysregulation, polyendocr-
inopathy, enteropathy, X-linked (IPEX) syndrome. Further in vitro studies indeed showed 
defective function of Treg cells despite normal FOXP3 protein expression and nuclear 
localization. The boy underwent hematopoietic stem cell transplantation at 11 years of 
age and despite the temporary development of diabetes while on prednisone is now 
doing much better, IgE levels have declined, and his fatigue has improved. This case 
illustrates that a classical pathogenic mutation in FOXP3 can lead to a clinical phenotype 
where the diagnosis of IPEX syndrome was never considered because of the lack of dia-
betes and the presence of only mild eczema, in addition to the normal Treg cell numbers 
and FOXP3 expression.
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taBLe 1 | Hematology and immunology parameters in the index case at 
presentation.
Laboratory results patient (7 years 
of age)
Normal range 
(5–12 years)
Hematology
• Hemoglobin (mmol/l) 7.0 6.0–9.0
• Platelets (106/ml) 220 150–350
• White blood cells (106/ml) 7.4 4–16
• Neutrophils (106/ml) 3.2 1.5–8.0
• Eosinophils (106/ml) 0.6 <0.5
• Monocytes (106/ml) 1.2 0.2–1.0
• Lymphocytes (total, 106/ml) 2.4 1.5–5.0
Immunology, humoral
• IgG (g/l) 6.8 6.0–10.3
• IgA (g/l) 0.26 0.3–1.7
• IgM (g/l) 0.27 0.2–0.75
• IgE (kU/l) 2,275 <100
Vaccine responsea
• Anti-PPS23 (ratio of 23 
serotypes)
1.28 >2.0
• Anti-Tet-Toxoid (ratio) 27.9 >2.0
Lymphocyte counts (cells/μl)
CD3+ T cells 1,424 700–3,500
• CD3+CD4+ T cells 691 300–2,100
• CD3+CD8+ T cells 745 200–1,200
CD4/CD8 ratio 0.9 0.9–3.6
CD3+CD4+CD8+ 50 <35
CD3−CD16+CD56+ NK cells 20 70–1,200
CD19+ B cells 15 100–600
aData were taken at day 0 prevaccination and day 35 postvaccination for comparison 
and divided to calculate a ratio. The ratio should be above 2.0, taking into account the 
concentration of antipneumococcal antibodies or antitetanus toxoid antibodies at start 
(when compared to immunized controls).
Ig, immunoglobulin.
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sUMMaRY
The constellation of early onset diabetes, infections, eczema, and 
elevated immunoglobulin (Ig) E levels with persistent and often 
severe diarrhea often results in the consideration of immune dys-
regulation, polyendocrinopathy, enteropathy, X-linked (IPEX) 
or IPEX-like syndromes. In general, we learn from whole exome 
and genome sequencing that the spectrum of circumscribed syn-
dromes is much broader than was previously appreciated, as also 
illustrated by a mild presentation of a classical mutation in the 
forkhead box protein 3 (FOXP3) gene c.1010G>A; p.(Arg337Gln) 
(reference sequence NM014009.3) believed to be highly penetrant 
and disease causative.
INtRoDUCtIoN
A boy born at term of Caucasian non-consanguineous parents 
presented with respiratory insufficiency immediately after 
birth due to tracheomalacia and a diaphragmatic paresis. A 
diaphragmatic plication was performed at the second month 
after birth. The patient suffered from severe pulmonary infec-
tions necessitating respiratory support repeatedly in the first 
years of life. Feeding difficulties started shortly after birth due 
to velopharyngeal insufficiency and gastroesophageal reflux and 
led to the placement of a percutaneous endoscopic gastrostomy 
tube in the first year after birth and veloplastic surgery at the 
age of 5  years. There was a persistence of loose stools, and an 
allergy was suspected. With the differential diagnosis of cow’s 
milk allergy, a hydrolysate was started (Neocate). Due to bloody 
diarrhea, a combined gastro-duodenoscopy and colonoscopy 
was performed when the boy was 3  years old. Histopathology 
showed macroscopic colitis and microscopic crypt abscesses and 
active chronic inflammation in the colon, duodenum, stomach, 
and esophagus. Therefore, inflammatory bowel disease was 
diagnosed. Immunosuppressive medication (including predni-
solone) was started which improved his stools and clinical well-
being. In the years that followed, the symptoms of diarrhea were 
under control by azathioprine with occasional flares. Attempts 
to reduce azathioprine dose led to an immediate increase in 
diarrhea. However, despite immunosuppressive medication and 
surgical corrective interventions, the feeding difficulties per-
sisted and pneumonias recurred. From the first day of life, there 
was a severe hypotonia and proximal muscle weakness causing a 
delayed motor development. A muscle biopsy suggested a mild 
deficiency of complex 1 of the mitochondrial respiratory chain, 
but this was never supported by genetic testing.
At the age of 7 years, the boy was sent to our clinical immu-
nology unit because of the recurrent infections and allergy with 
an elevated IgE of 2,275 kU/ml in the presence of a normal white 
blood cell count and Ig spectrum (Table 1). We met a coopera-
tive boy with a normal height, weight and head circumference, 
normal heart rate, respiration and saturation, and blood pres-
sure. He had a slightly flaccid face and was sitting in a wheel 
chair, yet able to walk for a small distance, and he had generally 
low muscle tone, muscular weakness, and Gower’s sign upon 
physical examination. We found normal eye movement, vision, 
and hearing and normal chewing, swallowing, and tongue 
movements. No signs of neuropathy, no ataxia, dysarthria, or 
speech impairment were found. Psychomotor development 
was normal otherwise, although he had low yet symmetrical 
reflexes.
Apart from a clear periodontitis, some pulmonary fine crackles 
at the end-inspiratory inhalation, and mild hepatomegaly, no other 
remarkable findings could be found, in particular, no splenomegaly 
or lymphadenopathy. The boy had a dry skin without obvious 
eczema, also not around the PEG insertion site for enteral feed-
ing. Apart from 350 ml daily enteral tube feeding (Nutrini Energy 
Multifiber), medication consisted of daily azathioprine (1.5 mg/kg 
body weight, bid).
Laboratory Findings
Upon laboratory investigations, complete blood count and differ-
entials were normal, and enzymatic liver tests, kidney, and thyroid 
function tests were within normal ranges. The initial immuno-
logical screening tests were abnormal with low to normal serum 
IgG, IgA, and IgM and very high IgE levels. Antibody response 
to pneumococcal polysaccharide vaccination (anti-PPS23) was 
deficient (Table 1). Fecal elastase levels were within the normal 
range excluding exocrine pancreatic dysfunction; calprotectin 
was elevated [ranging from normal (<50) to 1,159 μg/g of feces], 
and microbiological stool tests (bacterial, viral, and parasitic) 
were repeatedly normal.
FIGURe 1 | (a) The immunophenotyping of the T and B lymphocyte subsets of the patient was compared with the maturation of his 2-year-old brother who did not 
carry the mutation. (B) Standard screening of CD4+ regulatory T cells using CD127 and CD25 immunostaining (upper panel) was further supported by the 
assessment of a normal expression of intracellular forkhead box protein 3 (lower panel). (C) Function of the patient’s helper cell differentiation was tested by 
measuring the cytokines for the Th1 (IFNγ, TNFα), Th2 (IL-13), and Th17 (IL-17) in the supernatant of anti-CD3/anti-CD28-stimulated T cells as determined by 
Luminex (eBioscience, San Diego, CA, USA).
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Immunophenotyping and Functional tests
Lymphocyte enumeration was routinely done by flow cytometry 
and showed low numbers of B and NK cells with normal T cell 
numbers but a low CD4/CD8 ratio and increased CD4+CD8+ 
double-positive (DP) T cells (Table 1). The percentage of naïve 
and switched memory B cells was within age-specific reference 
ranges. CD4+ and CD8+ T cell differentiation into memory/
effector memory cells was normal (Figure 1A). The percentage of 
CD4+ regulatory T (Treg) cells determined by CD25 and CD127 
was found to be unremarkable, and the intracellular FOXP3 
FIGURe 2 | (a) Mutation c.1010G>A; p.(Arg337Gln) in the forkhead box protein 3 (FOXP3) gene identified using whole exome sequencing (gene on reverse strand). 
The index patient is hemizygous, and the mother is a heterozygous carrier (left panel). Mutation c.1010G>A; p.(Arg337Gln) in the FOXP3 gene is not present in the 
grandmother, I:1 (right panel). (B) The cosegregation study in the family showing that the mutation had occurred as a de novo change in the mother of the patient. 
Arrow indicates index patient.
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expression was comparable to healthy controls (Figure  1B). 
Lymphocyte activation using T cell stimuli such as anti-CD3/
anti-CD28 or IL-15 induced adequate proliferative responses of 
CD4+ and CD8+ T cells as assessed by carboxyfluorescein suc-
cinimidyl ester dilution (data not shown), although the cytokine 
release into the supernatant was considered high to normal, in 
particular for the Th2 signature cytokine IL-13 (Figure 1C).
Genetics
Whole exome sequencing (WES) was performed in a trio diag-
nostic approach (patient and both parents). In short, libraries 
were prepared using the Kapa HTP kit (Illumina, San Diego, CA, 
USA), and capture was performed using the SeqCap EZ Exome 
v3.0 (Roche Nimblegen Madison, WI, USA). Sequencing was done 
on an Illumina HiSeq2500 HTv4 (Illumina, San Diego, CA, USA) 
with paired-end 125-bp reads. Read alignment to hg19 and vari-
ant calling were done with a pipeline based on BWA-MEM0.7 and 
GATK 3.3. Variant annotation and prioritizing were done using 
Cartagenia NGS Bench (Cartagenia Inc., Cambridge, MA, USA). 
This revealed a hemizygous mutation c.1010G>A; p.(Arg337Gln) 
in the FOXP3 gene (NM_014009.3) in the patient. His mother 
was found heterozygous for the mutation (Figure 2A). This muta-
tion has been described as causal for IPEX syndrome (1–4) and is 
not present in the Exac database (http://exac.broadinstitute.org). 
Subsequent cosegregation showed that the mutation occurred 
de novo in the mother (Figure 2B).
treg Cell Function
Once the mutation in FOXP3 was found in the presence of 
normal FOXP3 protein expression, we analyzed the Treg cells 
more closely by investigating their functional capacities in vitro. 
Naïve CD45+CD4+CD25+ Treg cells from the patient and a 
healthy donor were expanded upon stimulation with anti-CD3/
anti-CD28. The cells were subsequently stained for the expression 
of the quintessential Treg cell transcription factors FOXP3 and 
Helios (Figure 3A) and the surface molecules CD25 and CTLA-4 
(Figure  3B). In both cases, the expression of those proteins 
was comparable to a healthy donor. Also, the Treg cells of the 
patient were able to normally produce both IL-10 and TGF-β 
and did not produce effector cytokines such as IFNγ (data not 
shown). Remarkably, the patient’s Treg cells presented an elevated 
presence of CD4+CD8+ DP cells that were also CD3+TCRαβ+ 
(Figures 3C,D).
Some FOXP3 mutations have been described to affect the 
nuclear localization of the protein (5); we therefore analyzed 
the nuclear localization of FOXP3 in the Treg cells of the patient 
by ImageStream (Figure 3E). Results showed a normal FOXP3 
nuclear distribution comparable to that of the healthy donor. 
Finally, we assessed the functional capacity of the Treg cells to sup-
press the proliferation of CD4+ and CD8+ T cells. Undoubtedly, 
the Treg cells were unable to fully suppress the proliferation 
of neither CD4+ nor CD8+ T cells, although the Treg cells still 
retained a limited capacity to suppress CD8+ T cell proliferation 
(Figure 3F).
BaCKGRoUND
History and Review
Immune dysregulation, polyendocrinopathy, enteropathy 
X-linked syndrome (OMIM304790) is an X-linked genetic 
disorder characterized by enteropathy, insulin-dependent type-1 
autoimmune diabetes mellitus (IDDM1), and eczema. Severe 
enteropathy manifesting as watery or bloody diarrhea is an early 
FIGURe 3 | (a) FACS panels showing the intracellular staining for forkhead box protein 3 (FOXP3) and Helios in the in vitro expanded regulatory T (Treg) cells from a 
healthy donor (in black) and the immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome patient (in red). (B) FACS plots displaying the 
expression of CD25 and CTLA-4. (C) FACS plots of CD4 and CD8 staining. Gate encloses the CD4+CD8+ double-positive (DP) cells. (D) Immunophenotyping for 
CD3 and TCRαβ of the cells in the gate in panel (C). (e) Representative images of ImageStream analysis from Treg and conventional T cells. Nuclear localization was 
confirmed by colocalization of the FOXP3 staining (purple) with the nuclear DAPI signal (in blue). (F) Graphs representing the proliferation of responder CD4+ or CD8+ 
T cells gated from total allogeneic peripheral blood mononuclear cells normalized to the proliferation of the responders only condition (0:1).
5
Tuijnenburg et al. Atypical IPEX with Classical FOXP3 Mutation
Frontiers in Pediatrics | www.frontiersin.org February 2017 | Volume 5 | Article 37
feature of the disease present in all IPEX syndrome patients. 
Furthermore, IDDM1 is common (>80%) and is diagnosed early, 
often within the first 1–3 months of life (6–11). It was found in 
4% of neonatal permanent diabetes among males (2). Other 
prominent symptoms due to profound immune dysregulation in 
males with IPEX syndrome include eczema/dermatitis (~65%), 
failure to thrive (~50%), thyroiditis (~30%), and recurrent infec-
tions (~20%). Autoimmune phenomena such as nephropathy, 
pneumonitis, hepatitis, vasculitis, arthritis, myositis, alopecia, 
and autoimmune cytopenias may be present (11, 12). The severe 
watery diarrhea and life-threatening infections reduce the lifes-
pan of these patients, and they usually die in the first years of life.
In case of elevated IgE levels, the first entities to be considered 
are atopic disease and allergy, parasitic infestations, Aspergillus 
infection (allergic bronchopulmonary aspergillosis) in cystic 
fibrosis, and secondary to HIV infection. Although allergy 
was indicated by positive RAST tests against milk protein, soja 
protein, casein, lactalbumin, lactoglobulin, and chicken protein, 
all other causes for the increased IgE levels were excluded in our 
patient. Primary immunodeficiency disorders (PIDs) such as 
hyper-IgE syndrome, Wiskott–Aldrich syndrome, leaky severe 
combined immunodeficiency/Omenn syndrome, autoimmune 
polyendocrinopathy-candidiasis-ectodermal dystrophy, or other 
rare disorders such as IPEX-like disease (for instance due to 
FOXP3, WASP, CD25, RAG1/2, AIRE, carbohydrate defect in 
glycosylation-variant PGM3 mutations, or STAT3 or STAT1 gain-
of-function mutations) were considered (13, 14).
In patients with PIDs, a breakdown of self-tolerance mecha-
nisms or immune dysregulation often exists, with high incidence 
of autoimmunity and autoinflammation as a consequence. In the 
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patients with IPEX syndrome, the lack of FOXP3 in lymphoid 
tissues (thymus, spleen, and lymph nodes), as encoded by the 
FOXP3 gene at Xp11.23-Xq13.3, leads to impaired development 
and suppressed function of CD4+CD25+ Treg cells. FOXP3 func-
tions as the master transcription factor for the development of 
Treg cells, in both human and mice, together with STAT5a, and 
the high-affinity IL-2 receptor CD25. Beyond its role in Treg cell 
differentiation, continuous FOXP3 expression is also required 
in mature Treg cells for their suppressive function and the full 
manifestation of the aforementioned key features of these Treg 
cells. The formation of Treg cell identity, characterized by its 
unique transcriptional program, requires the activation of addi-
tional genes. Indeed, enforced expression of the genes encoding 
IKAROS family zinc finger 4 (Eos), interferon regulatory factor 
4, SATB homeobox 1, lymphoid enhancer-binding factor 1, or 
GATA-binding protein 3 cooperate with FOXP3 to activate the 
expression of most, but still not all, of the Treg cell signature 
genes (15).
Immune Dysregulation and autoimmunity
The protein FOXP3 has four functional domains: an N-terminal 
proline-rich repressor domain, a zinc finger domain, a leucine 
zipper domain, and a C-terminal DNA-binding forkhead/winged 
helix domain. Mutations that affect any of these key functional 
domains may alter or abrogate the ability of the transcription fac-
tor to regulate gene expression in Treg cells. Mature naïve B cells 
from IPEX patients often express autoreactive antibodies, sug-
gesting an important role for Treg cells in maintaining peripheral 
B cell tolerance and B cell anergy (16–18).
The B cell numbers in our patients were rather low and 
showed an impaired pneumococcal polysaccharide vaccination 
response. Remarkably, there were no autoreactive antibodies 
detectable in our patient. Although anti-GAD or anti-islet cell 
antibodies were absent, a systematic investigation of all possible 
organ-specific autoantibodies was not performed. There was no 
evidence of autoimmune cytopenia. Also autoantibodies against 
nuclear antigens (ANA, ENA), neutrophil cytoplasmic proteins 
(ANCA-IFT, MPO, and PR3), and cardiolipin were all repeatedly 
negative (data not shown). Still, the complete lack of autoantibod-
ies cannot be confirmed definitely.
Classical Mutation but Variable 
penetrance
The pathogenicity of substitutions at position 337 (R337P and 
R337Q), similar to the one found in our patient, was reported 
previously in IPEX syndrome patients (1–4). In normal 
FOXP3, the side chain of arginine at position 337 is predicted 
to make close contact with the DNA backbone. The presence of 
a strong basic residue at this position is conserved in all fork-
head transcription factors and contributes to DNA binding 
through both hydrogen bonding and electrostatic interactions. 
The R337Q substitution destroys this close contact with the 
DNA backbone and is predicted to cause a significant loss of 
positive charge at the DNA-binding surface of FOXP3, previ-
ously suggested to result in a significant loss of DNA-binding 
affinity which leads to severe IPEX syndrome (2). Nonetheless 
our case is noticeably moderately affected—even though he is 
carrying the same deleterious mutation at the arginine posi-
tion 337.
DIsCUssIoN
Diagnosis
The immunological studies in our patient led to the identifica-
tion of a humoral immunodeficiency with low B cell counts. T 
cell numbers including Treg cells and their FOXP3 expression 
seemed normal. Only mild eczema was noted, and the use of local 
ointments other than cetomacrogol and vaseline cremors was not 
required. Past muscle biopsy and blood tests for pathological, 
biochemical, and metabolic causes had remained uninformative, 
and sequencing of his mitochondrial DNA did not result in an 
explanation for his muscular weakness. Yet, the diagnosis of 
inflammatory bowel disease at the age of 3 years is unusual and 
increased the chances of the cause being a monogenic disorder. 
A previous comparative genomic hybridization (CGH) array did 
not yield any relevant finding, and we did not diagnose the patient 
until WES was performed, which to our surprise resulted in the 
identification of a classical mutation in the FOXP3 gene which fits 
the diagnosis of IPEX syndrome. Even when the patient would 
not have presented with the myopathy, the absence of diabetes 
as well as the normal Treg cell number and FOXP3 expression 
refrained us from considering Sanger sequencing FOXP3 in first 
instance.
There are three evolutionally conserved non-coding sequences 
in the FOXP3 gene, one located at the 5′UTR of FOXP3 and 
identified as a Treg cell-specific demethylated region (19). This 
demethylated CpG island supports stable expression of FOXP3. 
This has been found to be constantly demethylated exclusively 
in Treg but not in T-effector cells, where it is fully methylated, 
which can be used to differentiate peripheral Treg from T-effector 
cells (which are CD25 and FOXP3 positive when activated during 
chronic inflammation) (17). In addition to its important role in 
both thymic and peripheral Treg cell differentiation, IL-2 signal-
ing also promotes stable FOXP3 expression in mature Treg cells. 
Although the Treg cell number was normal by standard pheno-
typing assays including IL-2Rα (CD25) and FOXP3 expression, 
their function was clearly impaired. The patient’s Treg cells were 
completely unable to suppress CD4+ T cell proliferation. Only a 
very limited capacity to suppress CD8+ T cells was spared in the 
Treg cells of the patient, very possibly linked to the yet functional 
expression of CD25, which has been shown to be the major sup-
pressive mechanism against CD8+ T cells (20). Also striking was 
the elevated presence of CD4+CD8+ DP cells derived from naïve 
Treg cells. These cells have been described in several autoimmune 
diseases, but their regulatory or inflammatory phenotype is still 
under debate (21).
treatment
Initial treatment of IPEX patients consists of immunosuppres-
sive medication which is often a combination of different drugs, 
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including corticosteroids and calcineurin inhibitors. The only 
curative treatment consists of hematopoietic stem cell transplan-
tation (HSCT). HSCT was performed at the age of 11 years with a 
matched unrelated donor (10/10 HLA class I/II), and after a short 
period of diabetes while being on prednisone because of mild 
graft-versus-host disease, he recovered fully and did not need any 
insulin afterward.
Post-HSCT, his IgE levels normalized within 6 months. Also 
his fatigue and daily activity improved which may be due to 
a combination of less pulmonary inflammation and myositis, 
a symptom that has been reported in IPEX syndrome before 
(1, 12). We cannot exclude that there are other defects not 
identified by CGH and WES that may explain part of his birth 
defects.
CoNCLUDING ReMaRKs
 1. Immune dysregulation, polyendocrinopathy, enteropathy, 
X-linked syndrome is a very rare disease. Patients with a mild 
presentation are likely to be underreported, and the true inci-
dence of the disease might actually be higher than is currently 
perceived, although in the era of WES and WGS, the number 
of reported cases have not steeply risen yet.
 2. Identical mutations in IPEX syndrome may vary from very 
severe to less penetrant disease, underpinning the lack of a 
clear-cut genotype–phenotype relationship.
 3. The number of CD4+CD25+FOXP3+ Treg cell may be com-
pletely normal in the presence of a genetically proven “classi-
cal” IPEX mutation.
 4. Immune dysregulation, polyendocrinopathy, enteropathy, 
X-linked syndrome may present with odd features, such as 
myopathy, B cell impairments, and CD4+CD8+ DP T cells.
 5. Hematopoietic stem cell transplantation is a curative proce-
dure in IPEX syndrome.
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